AI Matters
Why it matters
Anthropic launches drug discovery program for neglected diseases
The Decoder Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic has launched its own drug development program targeting neglected diseases that traditional pharmaceutical companies find unprofitable. The initiative aims to leverage AI to significantly reduce development timelines and improve clinical success rates.
Why it matters
It could accelerate treatments for unprofitable diseases, potentially cutting development times and doubling success rates.
Latest brief · Jul 22, 2026